AlgoThesis

Wire Screener Dashboard Go Pro

Watchlist

AAPL--

--

NVDA--

--

GOOGL--

--

BTCUSD--

--

Get Started Log In Not investment advice. Past performance ≠ future results.

Loading…

AlgoThesisThe news, with receipts.

Wire Screener Dashboard About RSS

Prices: Databento (EOD) · Filings: SEC EDGAR · Not investment advice. Past performance ≠ future results.Disclaimer Contact

Wire Screener Dashboard

SNY Sanofi Stock — fundamentals, financials & AI research · AlgoThesis

Stocks›Healthcare›SNY

SNY

Name: AlgoThesis
Author: algothesis

Sanofi

NasdaqResearch view

Healthcare · Pharmaceutical Preparations

OverviewFundamentals News Latest filings ↗

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR

SectorHealthcare

🔒 Market Cap—

🔒 Enterprise Value—

Income—

Sales—

Book/sh—

Cash/sh—

🔒 Dividend Est.—

Dividend TTM

Finviz-ordered snapshot — SEC EDGAR fundamentals live; 🔒 cells need a licensed price feed. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

Revenue history unavailable.

AI Bull vs Bear — SNY

Every story opens a two-sided AI breakdown — not just a headline.

All stories →

AbbVie would gain an experimental eczema drug by buying biotech: report

MarketWatch · 41d ago

Bull vs Bear →

COMMUNITY · $SNY0 theses

POST YOUR TAKE →

Related Stocks

Loading peers…

Ask AI about SNY Build basket with SNY Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.

SNY on the Wire

AbbVie would gain an experimental eczema drug by buying biotech: reportMarketWatch · Sat · 16:11

Latest on the Wire

Amazon beats cloud sales growth estimates; shares jumpInvesting.com · 4h ago The S&P 500 is making a change by adding this little-known industrial stockMarketWatch · Fri · 21:53 Apple revenue, profits beat expectations on iPhone sales but services miss targetsInvesting.com · Fri · 16:09

—

🔒 Dividend Ex-Date—

🔒 Dividend Gr. 3/5Y—

Payout—

Employees—

IPO—

🔒 P/E—

🔒 Forward P/E—

🔒 PEG—

🔒 P/S—

🔒 P/B—

🔒 P/C—

🔒 P/FCF—

🔒 EV/EBITDA—

🔒 EV/Sales—

Quick Ratio—

Current Ratio—

Debt/Eq—

🔒 LT Debt/Eq—

🔒 Option/Short—

EPS (ttm)—

🔒 EPS next Y—

🔒 EPS next Q—

EPS this Y—

🔒 EPS next Y %—

🔒 EPS next 5Y—

EPS past 3/5Y—

Sales past 3/5Y—

EPS Y/Y TTM—

Sales Y/Y TTM—

🔒 EPS Q/Q—

🔒 Sales Q/Q—

🔒 Earnings—

🔒 EPS/Sales Surpr.—

🔒 Insider Own—

🔒 Insider Trans—

🔒 Inst Own—

🔒 Inst Trans—

ROA—

ROE—

ROIC—

Gross Margin—

Oper. Margin—

Profit Margin—

🔒 SMA20—

🔒 SMA50—

🔒 SMA200—

🔒 Trades—

Shs Outstand—

🔒 Shs Float—

🔒 Short Float—

🔒 Short Ratio—

🔒 Short Interest—

🔒 52W High—

🔒 52W Low—

🔒 Volatility—

🔒 ATR (14)—

🔒 RSI (14)—

🔒 Beta—

🔒 Rel Volume—

🔒 Avg Volume—

🔒 Volume—

🔒 Perf Week—

🔒 Perf Month—

🔒 Perf Quarter—

🔒 Perf Half Y—

🔒 Perf YTD—

🔒 Perf Year—

🔒 Perf 3Y—

🔒 Perf 5Y—

🔒 Perf 10Y—

🔒 Recom—

🔒 Target Price—

🔒 Prev Close—

🔒 Price—

🔒 Change—

Ares Q2 2026 slides: record $36B fundraising drives 17% AUM growthInvesting.com · Fri · 14:54

Stock Market Today, July 30: Amazon Soars Over 8% After Hours on Earnings BeatThe Motley Fool · Fri · 14:11

The Wire scans sources on a rolling cadence — new stories land through the day.